Belden Inc.: Form 10-Q for the period ended Sep 29, 2019
Filed with the SEC on Nov 4, 2019 and accepted by EDGAR at Nov 4, 2019, 15:22 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-09-29. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-07-01 to 2019-09-29 | $620.3m | us-gaap:Revenues |
| Revenue | 9 months2019-01-01 to 2019-09-29 | $1.85bn | us-gaap:Revenues |
| Cost of revenue | 3 months2019-07-01 to 2019-09-29 | $384.9m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2019-01-01 to 2019-09-29 | $1.14bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-07-01 to 2019-09-29 | $235.4m | us-gaap:GrossProfit |
| Gross profit | 9 months2019-01-01 to 2019-09-29 | $701.2m | us-gaap:GrossProfit |
| Research and development | 3 months2019-07-01 to 2019-09-29 | $31.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2019-01-01 to 2019-09-29 | $100.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2019-07-01 to 2019-09-29 | $120.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2019-01-01 to 2019-09-29 | $365.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-07-01 to 2019-09-29 | −$280.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2019-01-01 to 2019-09-29 | −$174.9m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2019-07-01 to 2019-09-29 | $2.8m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2019-01-01 to 2019-09-29 | $13.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-07-01 to 2019-09-29 | −$297.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2019-01-01 to 2019-09-29 | −$229.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-07-01 to 2019-09-29 | −$6.70 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2019-01-01 to 2019-09-29 | −$6.04 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-07-01 to 2019-09-29 | −$6.70 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2019-01-01 to 2019-09-29 | −$6.04 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-07-01 to 2019-09-29 | 44,444,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2019-01-01 to 2019-09-29 | 41,090,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2019-01-01 to 2019-09-29 | $89.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2019-01-01 to 2019-09-29 | $74.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2019-01-01 to 2019-09-29 | $32.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2019-09-29 | $296.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-09-29 | $1.12bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-09-29 | $3.44bn | us-gaap:Assets |
| Current liabilities | At period end2019-09-29 | $577.5m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2019-09-29 | $1.40bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2019-09-29 | $1.14bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000913142-19-000018. Last ingested by Listed: Oct 29, 2026, 14:50 ET. Listed shows no prices and gives no investment advice.